Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 217, Issue 1, Pages -Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20190460
Keywords
-
Categories
Funding
- National Institute of Allergy and Infectious Diseases [R37 AI107494-01]
- National Institute of General Medicine Sciences Cell & Molecular Biology Training Grant [5T32GM007270]
- National Institute of Allergy and Infectious Diseases Immunology Training Grant [5T32AI106677]
Ask authors/readers for more resources
Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system that is believed to have an autoimmune etiology. As MS is the most common nontraumatic disease that causes disability in young adults, extensive research has been devoted to identifying therapeutic targets. In this review, we discuss the current understanding derived from studies of patients with MS and animal models of how specific cytokines produced by autoreactive CD4 T cells contribute to the pathogenesis of MS. Defining the roles of these cytokines will lead to a better understanding of the potential of cytokine-based therapies for patients with MS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available